179 related articles for article (PubMed ID: 33256984)
41. Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma.
Son SH; Park J; Jung MJ; Lee SK; Kim H; Kim KR; Park KK; Chung WY
Eur J Oral Sci; 2021 Feb; 129(1):e12750. PubMed ID: 33503283
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation.
Futakuchi M; Nannuru KC; Varney ML; Sadanandam A; Nakao K; Asai K; Shirai T; Sato SY; Singh RK
Cancer Sci; 2009 Jan; 100(1):71-81. PubMed ID: 19038005
[TBL] [Abstract][Full Text] [Related]
43. IGFBP3 deposited in the human umbilical cord mesenchymal stem cell-secreted extracellular matrix promotes bone formation.
Deng M; Luo K; Hou T; Luo F; Xie Z; Zhang Z; Yang A; Yu B; Yi S; Tan J; Dong S; Xu J
J Cell Physiol; 2018 Aug; 233(8):5792-5804. PubMed ID: 29219174
[TBL] [Abstract][Full Text] [Related]
44. Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.
Pandruvada SN; Yuvaraj S; Liu X; Sundaram K; Shanmugarajan S; Ries WL; Norris JS; London SD; Reddy SV
Int J Cancer; 2010 May; 126(10):2319-29. PubMed ID: 19816883
[TBL] [Abstract][Full Text] [Related]
45. Osteoclast differentiation by RANKL and OPG signaling pathways.
Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
[TBL] [Abstract][Full Text] [Related]
46. Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma.
Takayama Y; Mori T; Nomura T; Shibahara T; Sakamoto M
Int J Oncol; 2010 Jun; 36(6):1387-94. PubMed ID: 20428761
[TBL] [Abstract][Full Text] [Related]
47. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling.
Kim JY; Kim JY; Kim JJ; Oh J; Kim YC; Lee MS
Biol Pharm Bull; 2014; 37(2):255-61. PubMed ID: 24492722
[TBL] [Abstract][Full Text] [Related]
48. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.
Takai H; Kanematsu M; Yano K; Tsuda E; Higashio K; Ikeda K; Watanabe K; Yamada Y
J Biol Chem; 1998 Oct; 273(42):27091-6. PubMed ID: 9765225
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia Suppresses Spontaneous Mineralization and Osteogenic Differentiation of Mesenchymal Stem Cells via IGFBP3 Up-Regulation.
Kim JH; Yoon SM; Song SU; Park SG; Kim WS; Park IG; Lee J; Sung JH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563882
[TBL] [Abstract][Full Text] [Related]
51. The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling.
Lee Y; Hyung SW; Jung HJ; Kim HJ; Staerk J; Constantinescu SN; Chang EJ; Lee ZH; Lee SW; Kim HH
Blood; 2008 Jan; 111(2):885-93. PubMed ID: 17928529
[TBL] [Abstract][Full Text] [Related]
52. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
Quan J; Hou Y; Long W; Ye S; Wang Z
Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
[TBL] [Abstract][Full Text] [Related]
53. Significance of cancer stroma for bone destruction in oral squamous cell carcinoma using different cancer stroma subtypes.
Shan Q; Takabatake K; Kawai H; Oo MW; Inada Y; Sukegawa S; Fushimi S; Nakano K; Nagatsuka H
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35211756
[TBL] [Abstract][Full Text] [Related]
54. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
[TBL] [Abstract][Full Text] [Related]
55. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
[TBL] [Abstract][Full Text] [Related]
56. Regulation of osteoclastogenesis and RANK expression by TGF-beta1.
Yan T; Riggs BL; Boyle WJ; Khosla S
J Cell Biochem; 2001 Aug 1-9; 83(2):320-5. PubMed ID: 11573248
[TBL] [Abstract][Full Text] [Related]
57. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
[TBL] [Abstract][Full Text] [Related]
58. Bone destruction by invading oral squamous carcinoma cells mediated by the transforming growth factor-beta signalling pathway.
Goda T; Shimo T; Yoshihama Y; Hassan NM; Ibaragi S; Kurio N; Okui T; Honami T; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2615-23. PubMed ID: 20682990
[TBL] [Abstract][Full Text] [Related]
59. Anti-IFN-γ Antibody Promotes Osteoclastogenesis in Human Bone Marrow Monocyte-Derived Macrophages Co-Cultured with Tuberculosis-Activated Th1 Cells.
Deng J; Sun D; Luo F; Zhang Q; Chen F; Xu J; Zhang Z
Cell Physiol Biochem; 2018; 49(4):1512-1522. PubMed ID: 30205409
[TBL] [Abstract][Full Text] [Related]
60. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
